Free Trial

Ryan Specialty (RYAN) Competitors

Ryan Specialty logo
$64.87 -0.64 (-0.98%)
Closing price 03:59 PM Eastern
Extended Trading
$62.20 -2.67 (-4.11%)
As of 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RYAN vs. MFC, SLF, WTW, PUK, EG, PFG, CRBG, EQH, AEG, and KNSL

Should you be buying Ryan Specialty stock or one of its competitors? The main competitors of Ryan Specialty include Manulife Financial (MFC), Sun Life Financial (SLF), Willis Towers Watson Public (WTW), Prudential (PUK), Everest Group (EG), Principal Financial Group (PFG), Corebridge Financial (CRBG), Equitable (EQH), Aegon (AEG), and Kinsale Capital Group (KNSL). These companies are all part of the "insurance" industry.

Ryan Specialty vs.

Manulife Financial (NYSE:MFC) and Ryan Specialty (NYSE:RYAN) are both large-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.

52.6% of Manulife Financial shares are held by institutional investors. Comparatively, 84.8% of Ryan Specialty shares are held by institutional investors. 0.0% of Manulife Financial shares are held by insiders. Comparatively, 11.1% of Ryan Specialty shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Manulife Financial received 422 more outperform votes than Ryan Specialty when rated by MarketBeat users. Likewise, 68.05% of users gave Manulife Financial an outperform vote while only 43.18% of users gave Ryan Specialty an outperform vote.

CompanyUnderperformOutperform
Manulife FinancialOutperform Votes
460
68.05%
Underperform Votes
216
31.95%
Ryan SpecialtyOutperform Votes
38
43.18%
Underperform Votes
50
56.82%

In the previous week, Ryan Specialty had 6 more articles in the media than Manulife Financial. MarketBeat recorded 15 mentions for Ryan Specialty and 9 mentions for Manulife Financial. Manulife Financial's average media sentiment score of 1.53 beat Ryan Specialty's score of 0.98 indicating that Manulife Financial is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Manulife Financial
8 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Ryan Specialty
11 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Manulife Financial presently has a consensus price target of $45.50, suggesting a potential upside of 48.50%. Ryan Specialty has a consensus price target of $75.67, suggesting a potential upside of 15.68%. Given Manulife Financial's stronger consensus rating and higher possible upside, research analysts clearly believe Manulife Financial is more favorable than Ryan Specialty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Manulife Financial
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.00
Ryan Specialty
1 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.46

Manulife Financial has a net margin of 10.08% compared to Ryan Specialty's net margin of 9.14%. Ryan Specialty's return on equity of 48.01% beat Manulife Financial's return on equity.

Company Net Margins Return on Equity Return on Assets
Manulife Financial10.08% 15.98% 0.76%
Ryan Specialty 9.14%48.01%6.33%

Manulife Financial pays an annual dividend of $1.21 per share and has a dividend yield of 3.9%. Ryan Specialty pays an annual dividend of $0.48 per share and has a dividend yield of 0.7%. Manulife Financial pays out 58.5% of its earnings in the form of a dividend. Ryan Specialty pays out 69.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Manulife Financial has raised its dividend for 12 consecutive years. Manulife Financial is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Manulife Financial has higher revenue and earnings than Ryan Specialty. Manulife Financial is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Manulife Financial$45.58B1.16$4.05B$2.0714.80
Ryan Specialty$2.52B6.81$61.04M$0.6994.80

Manulife Financial has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, Ryan Specialty has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500.

Summary

Manulife Financial beats Ryan Specialty on 14 of the 22 factors compared between the two stocks.

Get Ryan Specialty News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYAN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RYAN vs. The Competition

MetricRyan SpecialtyInsurance agents, brokers, & service IndustryFinance SectorNYSE Exchange
Market Cap$17.13B$18.58B$11.12B$18.97B
Dividend Yield0.73%1.43%5.79%4.02%
P/E Ratio94.8023.7122.0032.71
Price / Sales6.815.8826.0927.84
Price / Cash27.4226.5517.6017.53
Price / Book17.4017.702.654.47
Net Income$61.04M$731.04M$1.03B$1.02B
7 Day Performance-6.02%-0.61%0.57%0.50%
1 Month Performance-11.35%-8.43%-0.43%-2.83%
1 Year Performance24.71%6.50%537.91%4.36%

Ryan Specialty Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RYAN
Ryan Specialty
3.6253 of 5 stars
$64.87
-1.0%
$75.67
+16.7%
+32.6%$16.99B$2.52B94.013,850Positive News
High Trading Volume
MFC
Manulife Financial
4.927 of 5 stars
$28.42
-0.7%
$45.50
+60.1%
+31.4%$48.83B$45.58B13.7340,000Upcoming Earnings
Analyst Revision
Positive News
SLF
Sun Life Financial
3.3345 of 5 stars
$56.60
+0.3%
N/A+16.8%$32.31B$28.68B14.7429,200Upcoming Earnings
Short Interest ↑
Analyst Revision
Positive News
WTW
Willis Towers Watson Public
3.1489 of 5 stars
$315.76
-1.6%
$346.38
+9.7%
+22.6%$31.48B$9.93B-315.7646,600Earnings Report
Analyst Forecast
Analyst Revision
PUK
Prudential
4.2561 of 5 stars
$20.50
-1.2%
N/A+20.9%$26.90B$8.14B8.8414,500Short Interest ↓
News Coverage
Positive News
EG
Everest Group
4.7045 of 5 stars
$343.54
-1.8%
$396.00
+15.3%
-2.1%$16.42B$17.08B10.942,430Earnings Report
Analyst Forecast
Gap Down
PFG
Principal Financial Group
4.3274 of 5 stars
$70.26
-2.6%
$84.69
+20.5%
-6.3%$15.81B$16.13B10.5219,300Earnings Report
Dividend Increase
Analyst Forecast
CRBG
Corebridge Financial
4.7875 of 5 stars
$27.01
-2.5%
$36.15
+33.9%
+11.4%$15.02B$19.06B7.157,700Upcoming Earnings
Positive News
EQH
Equitable
4.2092 of 5 stars
$45.65
-2.6%
$60.91
+33.4%
+34.0%$14.01B$12.44B11.958,200Earnings Report
Analyst Forecast
Positive News
AEG
Aegon
3.1894 of 5 stars
$6.07
-0.5%
N/A+4.2%$13.38B$19.52B6.3222,300
KNSL
Kinsale Capital Group
2.8156 of 5 stars
$471.03
-3.0%
$468.56
-0.5%
+19.7%$10.96B$1.59B26.48470Earnings Report
Analyst Forecast
Positive News

Related Companies and Tools


This page (NYSE:RYAN) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners